evidoria

← Back to browse

Good practice Imported

Max Planck Innovation — Germany's Patent-to-Startup Pipeline for Basic Research

Germany · Munich · See the Germany profile · See the Munich profile

Evidence: Observational / pre–post Top 64% 62/100 · Ask Evidence Copilot about this practice

Max Planck Innovation, the Max Planck Society's technology-transfer arm, has generated over €576m in exploitation revenue and helped launch 200+ spin-offs since 1970, including 4 unicorns — Europe's top-ranked research-to-startup pipeline in 2025.

5200 inventions
Inventions supported since 1970 (1970-2026)
3100 contracts
Commercial contracts since 1970 (1970-2026)
576 EUR million
Cumulative exploitation revenue (1970-2026)
200+ spin-offs
Spin-offs launched since 1990 (1990-2026)
9500 jobs
Jobs created via spin-offs
50 EUR billion
Publicly listed spin-off market value (December 2025)
14 spin-offs
New spin-offs in 2025 (2025)
4 unicorns
Spin-off unicorns (European ranking) (2025)
Max Planck Innovation — Germany's Patent-to-Startup Pipeline for Basic Research

Details

Maturity
Established
Promoter
Max Planck Innovation GmbH
Period
1970–2026 (ongoing)
Region (NUTS)
DE21
Keywords
technology transfer, patent licensing, deep tech, research commercialisation

Context

Max Planck Innovation GmbH is the Max Planck Society's technology-transfer subsidiary, commercialising research from the Society's 84 institutes since 1970.

Objectives

Screen invention disclosures, file patents, and negotiate licences and industry contracts on the Society's behalf to bring basic research to market.

Activities

The office screens roughly 140 invention disclosures a year, of which about two-thirds proceed to patent applications. In 2025 it recorded 131 disclosures, 105 patents, 70 contracts and 14 new spin-offs - almost double 2024.

Results

Since founding, it has supported more than 5,200 inventions and 3,100 commercial contracts, generating over 576 million euros in cumulative exploitation revenue. More than 200 spin-offs have launched since 1990 (160 directly supported), creating an estimated 9,500 jobs; seven are now publicly listed with a combined market value above 50 billion euros (December 2025), and the European Spinout Report 2025 ranked Max Planck first in Europe for spin-off unicorns (4) and aggregate spin-off value.

Conclusions

Evidence is strongest on commercialisation throughput and financial return; published reporting is not broken down by institute, region or founder demographics, so inclusion outcomes cannot be independently verified from public figures.

Implementation
Indicative cost
Medium (€50k–€500k) — Operates across the Max Planck Society's 84 institutes; no total operating-budget figure is stated, though cumulative exploitation revenue exceeds 576 million euros.
Time to results
Long (> 3 years) — Operating continuously since 1970, with 2025 activity (131 disclosures, 105 patents, 70 contracts, 14 spin-offs) almost double 2024's.
Staffing & skills
Max Planck Innovation GmbH (technology-transfer subsidiary of the Max Planck Society)

Conditions for success

  • Systematic annual screening of invention disclosures across all 84 Max Planck institutes
  • A dedicated pipeline from disclosure through patenting to licensing/spin-off creation

Common failure modes

  • Published reporting is not broken down by institute, region or founder demographics, so inclusion outcomes cannot be independently verified

Commonly funded by

National / regional programmes Horizon Europe

Indicative funding routes for practices of this type — always check each programme's current calls and eligibility rules.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful